|
|
NEWS From Loop and Learn
Speaker Series: Different Types of Diabetes, Bubblan, Replays
|
|
|
|
Different Types of Diabetes
| |
Dr. C.C. King, Diabetes Research ConnectionSunday, 24 October 2021, 5pm PDT (12am GMT)Join us:Zoom: https://us02web.zoom.us/j/81100950992
YouTube Livestream: https://www.youtube.com/c/LOOPandLEARN (This event will be recorded) Charles (C.C.) King is Board Chair/ President and Research Scientist with the Diabetes Research Connection (San Diego, CA). Dr. King may also talk about several of the funded projects underway at the Diabetes Research Connection, such as:
|
|
|
|
|
|
Did You Know?
FreeAPS v2.2 (202), which is a fork of Loop and not to be confused with FreeAPSX:
- Was updated with the same rileylink and pump improvements found in Loop v2.2.6
- Supports xDrip4iOS
If you are running an EmaLink or OrangeLink Pro, you should apply this patch:
- It's best to build Loop v2.2.6 or FreeAPS v2.2 (202) first to make sure you build successfully
- Then apply the patch and rebuild
|
|
|
|
|
Upcoming Event: Bubblan/Bubble
Please mark your calendars for this upcoming event:
Bubblan CGM & Transplantation Anton Beckman & Elsita Rosa Sunday, 7 November 2021, 5pm PDT (12am GMT) https://us02web.zoom.us/j/82478974148
|
|
|
|
|
Replay: Gastric/Digestive Issues in T1D
| |
Dr. Marina Basina & Dr. Linda Nguyen Stanford University
Though gastrointestinal (GI) complications are common among long-term T1Ds, changes in the gut begin as early as 6 months after diagnosis of T1D, even in young children. The awareness of these complications is low among physicians. Early identification and appropriate management of GI complications will improve both diabetic management and quality of life.
|
|
|
|
|
|
Replay: Dr. Elliot Botvinick, UC Irvine
|
|
Developer of iGLOBE(Insulin+Lactate+Oxygen+ Beta-hydroxybutyrate LifeStrip) iGLOBE is a first-of-its-kind device that will simultaneously measure insulin, glucose, lactate, oxygen, and the ketone body beta-hydroxybutyrate with a single probe inserted just beneath the skin. It will include continuous insulin monitoring and improve dosing efficacy by providing real-time feedback on the dynamics of insulin pump therapy as well as real-time estimates of a patient’s sensitivity to the insulin.
|
|
|
|
|
|
Replay: Dr. Nally, Pediatric Endocrinologist, Yale University School of Medicine
|
|
Laura Nally, MD works at Yale University as an Assistant Professor and receives funding from the National Institutes of Health to study metabolic changes that occur on very low carbohydrate diets in youth with T1D.
Below, you will find links to ISPAD guidelines for PreSchool T1Ds, as well as Dr. Nally's paper on Looping in Pregnancy.
|
|
|
|
|